Avoid sustained direct UV or strong visible light
New England Journal of Medicine (2025) The REDEFINE 1 Phase 3 trial was a landmark 68-week, double-blind, randomized study comparing CagriSema (cagrilintide 2.4 mg plus semaglutide 2.4 mg) with semaglutide alone, cagrilintide alone, and placebo in 3,417 adults with obesity or overweight without diabetes
Side effects are rare and typically mild, such as temporary irritation or redness at the injection site
Injectable vitamin B12 is administered intramuscularly (into a muscle), typically in the upper part of your arm
The peptide begins working quickly after injection, potentially preparing tissues for therapeutic exercise
Sourcing matters: Poor-quality versions exist